🇺🇸 FDA
Patent

US 8465743

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

granted A61PA61P35/00

Quick answer

US patent 8465743 (Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P35/00